Paper

Paper

Changelog Terms Privacy Issues Docs Support Foundation About

JAK2 or CALR mutation status defines subtypes of essentia... | ResearchHub

Paper

Paper

Supporters

Support the authors with ResearchCoin

Journal

Topics

Internal Medicine

Gastroenterology

DOI

10.1182/blood-2013-11-539098

Changelog Terms Privacy Issues Docs Support Foundation About

JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes

0

Authors

Elisa Rumi

Elisa Rumi•Ashot Harutyunyan•Mario Cazzola

Published

December 24, 2013

Abstract

Key Points JAK2 (V617F)-mutated essential thrombocythemia and polycythemia vera are different phenotypes in the evolution of a single neoplasm. CALR-mutated essential thrombocythemia is a distinct disease entity not only at the molecular level, but also with respect to clinical outcomes.

Supporters

Support the authors with ResearchCoin

Journal

Topics

Internal Medicine

Gastroenterology

DOI

10.1182/blood-2013-11-539098